Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland.
about
The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 ReactivationClinical impact of primary infection with roseolovirusesEarly developmental outcomes of children with congenital HHV-6 infection.The epidemiology of acute encephalitis.Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cellsHuman Herpesvirus 6A Exhibits Restrictive Propagation with Limited Activation of the Protein Kinase R-eIF2α Stress Pathway.Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.Human enteroviruses are not the cause of neurological impairments in children at the Korle-Bu Teaching HospitalViral pathogens in children hospitalized with features of central nervous system infection in a malaria-endemic region of Papua New Guinea.Herpes simplex serious neurological disease in young children: incidence and long-term outcome.Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitisHuman herpesvirus 6 and 7 in febrile status epilepticus: the FEBSTAT study.Human herpes virus 6B: a possible role in epilepsy?Causality in acute encephalitis: defining aetiologies.Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand.HHV-6 and seizure: A systematic review and meta-analysis.Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature.Did a then unknown virus, HHV-6/7, give rise to the whooping cough vaccine controversy of the 1970s?10-year-old male with fever and headache.Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.Human herpesviruses‐6 and ‐7 and neurological morbidity.Whole genome diversity of inherited chromosomally integrated HHV-6 derived from healthy individuals of diverse geographic origin.
P2860
Q21284983-23FE9AB6-1D41-4173-8A8D-AC8F02967B17Q27025365-9C9ADCB3-320D-48E4-B098-41F04CF853EEQ27345284-7F8FBF6A-9005-4C87-ACAF-C843F1D865EBQ33293110-622D7C45-51D1-4236-BF7A-F486667135CCQ33301426-8DD74B1E-E11C-4F38-9A80-0F76F656A8C7Q33564101-6B83DA50-925E-4CE1-AEED-E6CD51CF7647Q33636301-433C6F79-DF6C-42C1-9A1D-6DBED7ECF642Q34537814-E2FDEF1B-9E7C-4677-B836-489DEDCD3E4DQ34563993-2ABCE8D8-A8DA-460F-9C67-8635C1B2905AQ34659475-DEA2382E-B1B2-47BD-9A64-8E566A999767Q35668338-96ABDCBB-8431-46BE-A31F-414E322A97C8Q35784374-6F006CD5-DECC-449E-9CE8-EBA9B5B0EEB5Q36235638-C9E95DDA-D514-412F-BBFF-41A1B1EA568CQ37216740-DC237F82-79B7-45B7-B0B9-BF7CD50AE264Q37730228-D390E8C2-72A4-43A3-9610-5ABC4FA8F20CQ38467445-3A67F0CF-48AC-4EA7-978D-0104CBCD60E0Q38858240-62ABFF1E-4A7E-4C7F-A2A6-30A7504AD6D6Q39225855-B964FFC2-2D31-42C7-8176-0E9766156B92Q39662542-FE13862A-3C8D-42CD-A696-08DF1ACED309Q40390592-E6BB3637-5222-4480-AEDD-2F40F1FF7E51Q44189939-ABDE1980-9B66-48FC-B5D4-3A30ABE5C470Q45773152-5F5FCB70-3217-490F-BC5F-EB6DF1623C4DQ50284269-DABFBF85-C307-4859-81E3-957AA629A839
P2860
Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Human herpesviruses-6 and -7 e ...... bidity in Britain and Ireland.
@en
type
label
Human herpesviruses-6 and -7 e ...... bidity in Britain and Ireland.
@en
prefLabel
Human herpesviruses-6 and -7 e ...... bidity in Britain and Ireland.
@en
P2093
P2860
P356
P1476
Human herpesviruses-6 and -7 e ...... bidity in Britain and Ireland.
@en
P2093
P2860
P304
P356
10.1136/ADC.2004.062216
P407
P577
2005-06-01T00:00:00Z